Mirizzi syndrome caused by xanthogranulomatous cholecystitis: report of a case
- PMID: 9306594
- DOI: 10.1007/BF02384992
Mirizzi syndrome caused by xanthogranulomatous cholecystitis: report of a case
Abstract
Xanthogranulomatous cholecystitis (XGC) is a rare inflammatory disease of the gallbladder. In severe cases, inflammation extends to adjacent structures, and XGC is sometimes confused with a malignant neoplasm. We recently diagnosed XGC as the preoperative cause of Mirizzi syndrome in a patient based on the clinical course. The patient was admitted because of obstructive jaundice, with gallbladder carcinoma as the suspected cause. The gallbladder was swollen with gallstones and the serum level of carbohydrate antigen 19-9 (CA19-9) was 3070 U/ml at admission. A percutaneous transhepatic cholangiodrainage (PTCD) was done, and the common hepatic duct as well as the right and left hepatic ducts were found to be obstructed. Later, the CA19-9 level and swelling of the gallbladder decreased and the obstruction of the bile ducts disappeared. A cholecystectomy was performed and the intraoperative pathohistological diagnosis of chronic cholecystitis was made from frozen sections. The pathohistological diagnosis of XGC was made from paraffin-embedded sections. Mirizzi syndrome such as that seen in our patient is a rare complication of XGC. XGC occasionally causes extensive inflammation; thus, performing a conventional cholecystectomy can be unsafe. However, in our opinion, a total, not subtotal, cholecystectomy should be done whenever possible because the incidence of gallbladder carcinoma accompanied with XGC is higher than that with ordinary cholecystitis or gallstones.
Similar articles
-
Xanthogranulomatous cholecystitis: 15 years' experience.World J Surg. 2004 Mar;28(3):254-7. doi: 10.1007/s00268-003-7161-y. Epub 2004 Feb 17. World J Surg. 2004. PMID: 14961199
-
Xanthogranulomatous cholecystitis mimicking gallbladder cancer and causing obstructive cholestasis.Hepatobiliary Pancreat Dis Int. 2012 Oct;11(5):549-52. doi: 10.1016/s1499-3872(12)60223-9. Hepatobiliary Pancreat Dis Int. 2012. PMID: 23060404
-
Increased serum CA19-9 in patients with xanthogranulomatous cholecystitis.Hepatogastroenterology. 1998 Jan-Feb;45(19):77-80. Hepatogastroenterology. 1998. PMID: 9496491
-
[A case of early cystic duct carcinoma concomitant with xanthogranulomatous cholecystitis (XGC)].Nihon Shokakibyo Gakkai Zasshi. 2011 Oct;108(10):1743-51. Nihon Shokakibyo Gakkai Zasshi. 2011. PMID: 21971149 Review. Japanese.
-
Xanthogranulomatous cholecystitis: a review of 31 patients.Surg Endosc. 2021 Jul;35(7):3874-3880. doi: 10.1007/s00464-020-07828-6. Epub 2020 Jul 27. Surg Endosc. 2021. PMID: 32720174 Review.
Cited by
-
Outcomes of Xanthogranulomatous cholecystitis in laparoscopic era: A retrospective Cohort study.J Minim Access Surg. 2013 Jul;9(3):109-15. doi: 10.4103/0972-9941.115368. J Minim Access Surg. 2013. PMID: 24019688 Free PMC article.
-
Xanthogranulomatous cholecystitis: 15 years' experience.World J Surg. 2004 Mar;28(3):254-7. doi: 10.1007/s00268-003-7161-y. Epub 2004 Feb 17. World J Surg. 2004. PMID: 14961199
-
Xanthogranulomatous Cholecystitis Mimicking Carcinoma Gallbladder.Case Reports Hepatol. 2023 Feb 13;2023:2507130. doi: 10.1155/2023/2507130. eCollection 2023. Case Reports Hepatol. 2023. PMID: 36815138 Free PMC article.
-
What should be done in patients diagnosed with xanthogranulomatous cholecystitis? Case-control study.North Clin Istanb. 2020 Sep 1;7(5):467-470. doi: 10.14744/nci.2020.35848. eCollection 2020. North Clin Istanb. 2020. PMID: 33163882 Free PMC article.
-
Xanthogranulomatous cholecystitis expressing high levels of DUPAN-II.J Gastroenterol. 2007 Jul;42(7):593-6. doi: 10.1007/s00535-007-2063-7. Epub 2007 Jul 25. J Gastroenterol. 2007. PMID: 17653657